effort
circumv
resist
rapamycin
mtor
inhibitor
search
novel
rapamycindownstreamtarget
may
key
player
respons
cancer
cell
therapi
found
rapamycin
nm
concentr
increas
phosphoryl
eukaryot
initi
factor
eif
rapamycinsensit
estrogendepend
cell
minim
effect
phosphoryl
rapamycininsensit
tripleneg
cell
addit
salubrin
inhibitor
dephosphorylationdecreas
express
surfac
marker
associ
capac
self
renew
increas
senesc
induc
clonogen
cell
death
suggest
excess
phosphoryl
detriment
cell
surviv
treat
cell
salubrin
enhanc
radiationinduc
increas
phosphoryl
clonogen
death
show
irradi
cell
sensit
increas
phosphoryl
nonirradi
one
similar
salubrin
phosphomimet
variant
increas
sensit
radiat
abrog
radiationinduc
increas
breast
cancer
type
suscept
gene
thu
implic
enhanc
phosphoryl
modul
dna
repair
inde
salubrin
inhibit
nonhomolog
end
join
well
homolog
recombin
repair
doubl
strand
break
induc
iscei
green
fluoresc
protein
report
plasmid
addit
effect
radiat
salubrin
enhanc
phosphoryl
clonogen
death
respons
histon
deacetylas
inhibitor
vorinostat
final
catalyt
competit
inhibitor
mtor
increas
phosphoryl
demonstr
involv
mtor
activ
modul
phosphoryl
experi
suggest
excess
phosphoryl
decreas
surviv
cancer
cell
make
worthi
target
drug
develop
potenti
enhanc
cytotox
effect
establish
antineoplast
therapi
circumv
resist
rapalogu
possibl
drug
inhibit
upstream
compon
mtor
pathway
phosphatidylinositol
protein
kinas
bmammalian
target
rapamycin
pathway
regul
cell
growth
prolifer
deregul
pathway
underli
oncogen
transform
modul
antineoplast
treatment
affect
outcom
mtor
inhibitor
rapamycin
derivativesdecreas
cancer
cell
prolifer
test
anticanc
agent
clinic
trial
rapamycin
use
coat
stent
prevent
angiographicrestenosi
fda
approv
immunosuppress
deriv
temsirolim
everolim
approv
treatment
variou
type
cancer
rapalogu
bind
intracellular
receptor
bind
protein
form
complex
inhibit
mtor
complex
bind
mtor
rapamycinbind
domain
moreov
prolong
incub
rapalogu
inhibit
format
mtor
complex
howev
effect
rapalogu
cell
type
specif
may
depend
rel
abund
molecul
particip
makeup
mtorc
macromolecular
complex
consequ
inhibitori
outcom
rapalogu
tumor
growth
univers
therefor
rapamycinsensit
cancer
cell
delin
rapamycin
downstream
effector
modul
tumor
growth
respons
antineoplast
treatment
like
lead
discoveri
new
compound
inhibit
tumor
growth
andor
enhanc
sensit
establish
therapi
molecul
expect
circumv
resist
cancer
cell
drug
target
upstream
compon
pathway
partial
effect
global
activ
present
studi
report
inhibit
mtor
lead
increas
phosphoryl
subunit
date
contrast
report
publish
regard
involv
mtor
phosphoryl
howev
present
studi
demonstr
estrogendepend
rapamycinsensit
breast
cancer
cell
well
tripl
neg
rapamycininsensit
cell
inhibit
mtor
rapamycin
specif
catalyt
inhibitor
respect
lead
increas
phosphoryl
bound
gtp
recruit
met
ribosom
scan
cap
mrna
follow
recognit
initi
codon
gtp
hydrolysi
inact
releas
recycl
activ
complex
via
interact
guanin
nucleotid
exchang
factor
normal
physiolog
condit
facilit
interact
howev
phosphoryl
ser
turn
substrat
competit
inhibitor
lead
reduct
level
met
complex
attenu
global
protein
translat
importantli
cellular
level
excess
slight
increas
phosphoryl
sequest
major
fraction
mammalian
cell
phosphoryl
four
differ
kinas
respond
differenti
variou
stress
signal
dephosphoryl
conduct
catalyt
subunit
phosphoprotein
phosphatas
complex
specif
regulatori
subunit
eg
constitut
repressor
phosphoryl
crep
stressinduc
growth
arrest
dna
damag
induc
protein
salubrin
inhibitor
dephosphoryl
interfer
associ
regulatori
subunit
therebi
lead
increas
phosphoryl
applic
variou
cell
system
vitro
employ
elucid
physiolog
relev
increas
phosphoryl
cell
surviv
molecular
outcom
physiolog
relev
increas
phosphoryl
extens
studi
endoplasm
reticulum
er
overload
gener
thought
exert
protect
role
respons
increas
er
load
pkrlike
erloc
kinas
perk
activ
transient
increas
phosphoryl
ensu
lead
global
attenu
protein
translat
may
go
hand
hand
increas
translat
specif
mrna
possess
either
internalribosomeentrysit
element
short
open
read
frame
leader
global
attenu
protein
translat
diminish
er
load
specif
protein
whose
translat
increas
activ
transcript
gene
modul
cellular
respons
stress
allevi
phosphoryl
requir
order
enabl
translat
new
transcriptom
exposur
mous
embryon
fibroblast
mef
anticanc
agent
doxorubicin
histon
deacetylas
inhibitor
also
led
increas
phosphoryl
albeit
sustain
rather
transient
one
studi
modifi
mef
carri
nonphosphorylat
aa
mutat
show
higher
sensit
drug
ss
wildtyp
counterpart
lead
conclus
druginduc
increas
phosphoryl
protect
cell
death
howev
tightli
regul
phosphoryl
may
protect
excess
sustain
phosphoryl
may
harm
total
abrog
inde
note
tightli
regul
phosphoryl
requir
proper
embryon
develop
defici
phosphoryl
signal
due
homozygos
aa
well
excess
phosphoryl
result
knockout
crep
mutat
lead
inhibit
dephosphoryl
associ
fetal
anemia
growth
retard
also
mutat
perk
inhibit
phosphoryl
result
betacel
death
wolcottrallison
syndrom
similarli
excess
phosphoryl
tsc
mutat
cell
follow
exposur
er
stressor
inhibit
express
stressinduc
transcriptom
lead
cell
death
studi
implic
sustain
excess
phosphoryl
inhibit
dna
repair
develop
senesc
decreas
express
surfac
marker
associ
capac
self
renew
therebi
provid
rational
associ
increas
sensit
antineoplast
treatment
ioniz
radiat
histon
deacetylas
inhibitor
hdaci
result
suggest
develop
drug
increas
phosphoryl
may
provid
addit
mean
enhanc
sensit
establish
antineoplast
therapi
andor
circumv
resist
drug
target
upstream
compon
pathway
cell
cultur
breast
cancer
cell
line
american
type
cultur
collect
manassa
va
plate
densiti
per
cm
maintain
describ
cell
irradi
hour
postplat
cs
irradi
gammacel
elan
dose
rate
cgyminut
xray
irradi
polari
seri
ii
dose
rate
cgyminut
rapamycin
vorinostat
lc
laboratori
boston
selleck
houston
tx
salubrin
germani
ad
cultur
stock
solut
dimethyl
sulfoxid
dmso
control
cultur
receiv
equal
effector
mtor
modul
dna
repair
amount
vehicl
dmso
concentr
medium
exceed
drug
ad
cultur
immedi
follow
radiat
plate
coloni
surviv
assay
coloni
count
calcul
surviv
fraction
perform
triplic
describ
unless
otherwis
note
coloni
fix
stain
count
day
follow
plate
coloni
control
possess
cell
theoret
addit
effect
combin
antineoplast
treatment
cellsurviv
calcul
accord
follow
formula
x
sfa
x
sfb
sfa
surviv
fraction
cell
treat
agent
sfb
surviv
fraction
cell
treat
agent
b
experiment
determin
surviv
fraction
lower
calcul
one
indic
two
agent
enhanc
rather
addit
inhibitori
effect
cell
surviv
underli
assumpt
equat
agent
act
independ
within
popul
cellular
fraction
percent
surviv
treatment
equal
fraction
theoret
addit
inhibitori
effect
agent
b
size
kill
cellular
fraction
percent
ifab
equal
prepar
cell
lysat
analysi
treatmentinduc
chang
protein
level
phosphoryl
done
describ
minor
modif
protein
content
determin
bicinchonin
acid
reagent
biorad
hercul
ca
equal
load
verifi
measur
absorb
nm
ponceau
sigma
stloui
mo
extract
pb
individu
strip
twin
run
blot
expos
xray
film
chemiluminesc
follow
treatment
west
pico
ecl
reagent
thermo
scientif
rockford
il
valu
integr
light
densiti
autoradiogram
obtain
imag
j
nih
softwar
employ
determin
treatmentinduc
chang
protein
level
ratio
phosphoryl
total
level
protein
rabbit
antibodi
recogn
either
phosphoryl
nonphosphoryl
cell
signal
technolog
boston
antibodi
clone
santa
cruz
biotechnolog
inc
dalla
tx
control
salubrin
treat
cell
detach
nonenzymat
cell
dissoci
solut
sigma
israel
incub
human
serum
fcr
block
reagent
fluoresc
isothiocyan
fitc
antiesa
isotyp
control
miltenyi
biotec
germani
ebiosci
san
diego
ca
serv
viabil
dye
detect
cell
stain
perform
facscalibur
use
quest
softwar
bd
bioscienc
san
jose
ca
describ
keshet
et
al
stain
surfac
cell
stain
kit
cell
signal
technolog
use
cell
stain
photomicrograph
stain
cell
obtain
nikon
eclips
invert
microscop
nikon
ds
camera
nonhomolog
end
join
nhej
repair
assay
hela
cell
homolog
recombin
repair
hrr
assay
cell
stabli
transfect
pejssa
pdrgfp
respect
hela
cell
gift
dr
dahmdaphi
univers
hamburg
gift
dr
sculli
harvard
medic
school
assay
perform
essenti
describ
moyal
et
al
seluanov
et
al
except
cell
treat
salubrin
hour
prior
transfect
plasmid
express
iscei
empti
vector
control
measur
nhej
cell
cotransfect
iscei
express
vector
ratio
transfect
perform
dna
transfect
reagent
miru
bio
llc
accord
manufactur
instruct
parallel
wild
type
gfp
dsred
express
cell
well
neg
control
use
fac
calibr
adjust
voltag
color
compens
nhej
activ
follow
note
time
posttransfect
iscei
monitor
gfp
express
dsred
express
cell
detect
perform
facscalibur
event
per
sampl
determin
hr
activ
fraction
iscei
depend
gfp
express
cell
divid
transfect
effici
cell
describ
moyal
et
al
experiment
condit
effect
salubrin
averag
fluoresc
intens
gfp
express
cell
alway
less
indic
note
effect
salubrin
dna
repair
result
inhibit
translat
also
shown
tabl
file
salubrin
alter
cell
cycl
distribut
cell
indic
inhibitori
effect
salubrin
hrr
activ
follow
transfect
iscei
result
direct
inhibit
repair
effect
fraction
cell
phase
gift
dr
ron
laboratori
new
york
ny
transient
transfect
carri
jetpei
polyplu
new
york
ny
accord
manufactur
instruct
transfect
perform
cm
cultur
dish
plasmid
incub
ml
growth
medium
without
antibiot
hour
ad
ml
medium
proceed
experiment
protocol
transfect
carri
well
dish
note
amount
plasmid
incub
ml
growth
medium
without
antibiot
hour
ad
ml
medium
proceed
experiment
protocol
express
report
protein
monitor
western
blot
tabl
file
unpair
student
test
one
sampl
test
logarithm
transform
employ
statist
analysi
p
consid
statist
signific
previous
demonstr
estrogen
depend
breast
cancer
cell
highli
sensit
rapamycin
ic
nm
contrast
tripl
neg
insensit
drug
ic
nm
due
rel
high
level
phosphatid
acid
compet
rapalogu
bind
frb
domain
result
also
show
cell
rapamycin
induc
clonogen
death
ic
nm
cell
concentr
significantli
affect
cell
surviv
tabl
file
nm
concentr
rapamycin
led
increas
phosphoryl
much
pronounc
figur
ab
ioniz
radiat
hand
increas
phosphoryl
experi
decreas
total
level
irradi
cell
note
howev
differ
statist
signific
cell
level
well
total
level
decreas
greatli
hour
follow
irradi
elev
ratio
achiev
hour
postirradi
maintain
determin
relev
increas
phosphoryl
cell
surviv
treat
cell
salubrin
inhibitor
dephosphoryl
salubrin
led
dosedepend
increas
phosphoryl
associ
increas
clonogen
death
figur
b
tabl
combin
treatment
salubrin
concentr
affect
cell
surviv
radiat
led
increas
phosphoryl
associ
enhanc
clonogen
death
figur
c
tabl
tabl
file
interestingli
cell
receiv
combin
treatment
salubrin
gy
phosphoryl
similar
obtain
cell
treat
salubrin
alon
suggest
irradi
cell
suscept
increas
phosphoryl
nonirradi
cell
enhanc
sensit
radiat
also
note
salubrin
treat
cell
tabl
file
similar
effect
salubrin
transient
transfect
phosphomimet
variant
decreas
plasmiddosedepend
manner
clonogen
surviv
rel
observ
cell
transfect
nonphosphorylat
variant
high
plasmid
concentr
figur
surviv
cell
express
phosphomimet
variant
lower
cell
express
nonphosphorylat
variant
howev
lower
plasmid
concentr
affect
surviv
rel
figur
b
led
increas
clonogen
death
irradi
cell
figur
c
tabl
experiment
report
tumorigen
breast
cancer
stem
cell
enrich
subpopul
cell
express
cd
cd
lowesa
surfac
subpopul
express
similar
combin
cellsurfac
marker
identifi
breast
cancer
cell
line
shown
possess
high
capac
self
renew
tumor
initi
cell
cd
cd
sort
cell
surfac
esa
express
cell
serv
indic
chang
size
cellular
fraction
self
renew
capac
note
figur
treat
cell
salubrin
decreas
express
esa
cell
surfac
suggest
deleteri
effect
excess
phosphoryl
may
diminish
capac
self
renew
coloni
irradi
salubrin
treat
cell
contain
enlarg
senesc
look
cell
count
cell
coloni
form
follow
exposur
gy
salubrin
combin
radiat
salubrin
untreat
control
interestingli
even
though
combin
treatment
salubrin
gy
lead
enhanc
clonogen
death
tabl
lead
enhanc
appear
senesc
look
cell
figur
stain
acid
show
larg
cell
express
enzym
indic
inde
salubrin
enhanc
senesc
irradi
cell
figur
radiat
led
increas
level
protein
particip
dna
repair
follow
radiat
damag
increas
abrog
salubrin
transient
express
phosphomimet
figur
salubrin
increas
activ
senescenceassoci
cell
plate
coloni
surviv
assay
salubrin
vehicl
ad
immedi
follow
radiat
gy
acid
activ
reflect
blue
stain
number
averag
senesc
look
cellscoloni
sd
triplic
plate
differ
combin
treatment
one
sole
treatment
well
treatment
control
statist
signific
p
suggest
excess
phosphoryl
modul
dna
damag
repair
figur
inde
experi
hela
cell
cell
express
report
plasmid
nhej
hrr
respect
show
salubrin
inhibit
repair
isceiinduc
dsb
via
mechan
figur
similar
radiat
hdaci
vorinostat
also
lead
increas
phosphoryl
increas
thought
mean
cellular
protect
damag
howev
combin
low
concentr
salubrin
vorinostat
concentr
individu
hardli
affect
phosphoryl
result
increas
phosphoryl
associ
increas
clonogen
death
figur
tabl
tabl
file
specif
mtor
inhibitor
compet
atp
bind
catalyt
site
enzym
addit
rapamycin
insensit
cell
led
increas
phosphoryl
coupl
decreas
clonogen
surviv
show
inde
mtor
activ
modul
figur
tabl
tabl
file
previou
find
inhibit
mtor
increas
sensit
cell
ioniz
radiat
prompt
us
search
rapamycin
downstream
target
mediat
radiosensit
effect
even
though
sever
studi
reach
conclus
phosphoryl
autophagi
hypoxia
lie
either
upstream
parallel
rapamycin
sensit
pathway
took
special
note
work
kubota
et
al
show
saccharomyc
cerevisia
rapamycin
increas
phosphoryl
via
activ
work
progress
later
studi
show
temsirolim
concentr
higher
induc
phosphoryl
temsirolimousresist
cell
nm
concentr
rapamycin
induc
phosphoryl
acut
myeloid
leukemia
cell
nonetheless
recent
mounir
et
al
demonstr
inhibit
mef
lead
inhibit
akt
consequ
activ
perk
phosphoryl
relev
find
earlier
work
sarbassov
et
al
show
long
incub
rapamycin
destabil
lead
inactiv
akt
taken
togeth
two
report
suggest
inhibit
mtor
could
potenti
lead
increas
phosphoryl
howev
mounir
et
al
thoreen
et
al
treat
cell
mef
specif
catalyt
inhibitor
conclud
categor
inhibit
mtor
affect
phosphoryl
remain
determin
phenomenon
demonstr
studi
eg
increas
phosphoryl
follow
inhibit
mtor
rapalogu
result
inactiv
akt
pathway
whether
addit
mtor
mediat
pathway
involv
howev
clearli
shown
prolong
incub
cancer
cell
mtor
inhibitor
lead
sustain
elev
phosphoryl
import
note
though
deregul
mtor
lead
er
overload
increas
phosphoryl
show
either
deregul
increas
mtor
activ
inhibit
lead
similar
effect
phosphoryl
whether
phenomenon
regul
kinas
remain
determin
chemic
screen
compound
protect
cell
er
stress
led
discoveri
salubrin
inhibitor
dephosphoryl
salubrin
protect
cell
tunicamycininduc
er
stress
enhanc
er
stress
pancreat
cell
expos
fatti
acid
suggest
final
physiolog
outcom
increas
phosphoryl
depend
upon
type
stress
signal
kinas
relay
durat
signal
type
cell
involv
process
enhanc
phosphoryl
follow
exposur
salubrin
allevi
er
stress
caus
mainli
accumul
unfold
protein
er
howev
case
fatti
acid
excess
sustain
phosphoryl
effector
mtor
modul
dna
repair
plo
one
wwwplosoneorg
may
aggrav
cell
damag
interf
activ
stress
respons
consequ
fatti
acid
oxid
thu
lead
accumul
lipid
droplet
enhanc
initi
damag
mef
homozyg
aa
also
employ
mani
studi
demonstr
role
phosphoryl
play
regul
pathway
cell
surviv
decreas
surviv
cell
taken
proof
protect
role
play
phosphoryl
howev
interpret
take
account
possibl
mention
regul
phosphoryl
may
protect
total
abrog
well
excess
manifest
may
equal
harm
experi
salubrin
variant
show
sustain
increas
phosphoryl
detriment
cell
surviv
also
show
level
phosphoryl
toler
nonirradi
cell
harm
irradi
one
fact
treatment
salubrin
decreas
express
surfac
esa
suggest
increas
phosphoryl
like
affect
self
renew
capac
cell
interest
find
enhanc
phosphoryl
irradi
cell
abrog
radiationinduc
increas
level
quit
possibl
translat
machineri
damag
irradi
cell
tabl
file
doi
effector
mtor
modul
dna
repair
one
way
increas
phosphoryl
beyond
certain
level
hinder
activ
also
possibl
excess
phosphoryl
presenc
radiationinduc
kinas
lead
proteasom
degrad
possibl
dna
repair
protein
hypothesi
line
recent
find
raven
et
al
demonstr
increas
pkr
perk
activ
presenc
increas
phosphoryl
lead
proteasom
degrad
cyclin
work
progress
kim
et
al
show
cell
express
radiat
increas
er
stress
lead
activ
perk
increas
phosphoryl
autophagi
sensit
radiat
previous
shown
similar
rapamycin
radiat
lead
inhibit
function
remain
determin
experiment
condit
radiat
rapamycin
also
inactiv
function
thu
lead
activ
perk
possibl
kinas
whether
addit
pathway
involv
process
final
best
knowledg
experi
connect
first
time
excess
phosphoryl
genotox
stress
inhibit
dna
repair
pertin
experi
recent
studi
chen
et
al
demonstr
rapamycin
inhibit
homolog
nonhomolog
end
join
dna
repair
cell
importantli
fact
sustain
excess
phosphoryl
interfer
dna
repair
implic
continu
stress
signal
exposur
toxin
sustain
er
load
genet
instabl
conclus
demonstr
downstream
effector
mtor
pathway
excess
phosphoryl
interfer
dna
repair
process
neg
affect
surviv
cancer
cell
result
suggest
target
potenti
effect
establish
antineoplast
therapi
help
circumv
resist
rapalogu
effector
mtor
modul
dna
repair
induc
chang
e
p
ratio
pe
repres
analysi
determin
nm
determin
nm
denot
signific
chang
rel
control
p
valu
e
p
pe
nm
two
determin
present
tabl
file
file
tabl
doc
figur
variant
alter
radiationinduc
phosphoryl
endogen
cell
transfect
plasmid
express
nonphosphorylat
sa
phosphomimet
sd
process
analysi
phosphoryl
hour
postirradi
tif
